Friday, April 22, 2005

Bextra in the E.U.: No re-introduction

From various sources including the website, Google, and AP:

The European Medicines Agency said this week that pending the conclusion of its review of Cox-2 inhibitors, expected in June 2005, Bextra should not be reintroduced in the European Union market.

Hearings are to be held with the companies at the next CHMP meeting May 23-26.

Since the April 7 withdrawal in the U.S., Bextra sales have also been suspended in the European Union, Canada, Hong Kong, Singapore, Malaysia, South Africa, the Philippines and Mexico.

The review of Cox-2 inhibitors by EMEA began in October 2004 at the request of the European Commission.